Search Results 231-240 of 2984 for 必应搜索引擎留痕咨询邮箱:lgooxc@hotmail.com
About this study · Cohort A: Colorectal cancer (CRC); · Cohort B: Gastric and gastroesophageal junction (GEJ) cancer; · Cohort C: Triple-negative breast cancer ( ...
Metabolites are susceptible to a large number of "pre-analytic" sources of variability that should be addressed before samples are collected. The core staff has ...
Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...
The aim of this study is to evaluate the relation of the acute pacing threshold (volts at 'x' pulse width) to the chronic pacing threshold of a pacemaker/ICD ...
About this study. The purpose of this study is to assemble a collection of serial plasma biospecimens from women with ovarian, primary peritoneal, ...
A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy ...
About this study. The purposes of this study are to validate noninvasive hemoglobin monitoring in postoperative orthopedic pediatric patients, ...
Collaborators. Dr. Ross is involved in various research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators.
About this study. The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + ...
This will help determine the safety and feasibility of using cell-based regenerative therapy as an additional treatment for the management of HLHS.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.